increased tumor incidence_Eomes<tm1.1Bflu>/Eomes<tm1.1Bflu>,Tg(Cd4-cre)1Cwi/0

http://metadb.riken.jp/0002020IC57BL6DBA2SJLEomestm11BfluEomestm11BfluTgCd4cre1Cwi0TgCd4cre1CwiEomestm11Bflu

increased tumor incidence_Eomes<tm1.1Bflu>/Eomes<tm1.1Bflu>,Tg(Cd4-cre)1Cwi/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• eomesodermin
  http://metadb.riken.jp/db/mgi_rdf/MGI:1201683
• transgene insertion 1, Christopher B Wilson
  http://metadb.riken.jp/db/mgi_rdf/MGI:2448688

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Eomes<tm1.1Bflu>/Eomes<tm1.1Bflu>,Tg(Cd4-cre)1Cwi/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Cd4-cre)1Cwi|Eomes<tm1.1Bflu>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * DBA/2 * SJL

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased tumor incidence
  http://purl.obolibrary.org/obo/MP_0002020

文献

http://purl.org/net/cito/citesAsAuthority

• Yibei. Zhu, et.al., T-bet and eomesodermin are required for T cell-mediated antitumor immune responses., Journal of immunology (Baltimore, Md. : 1950), 2010, 185
  http://rdf.ncbi.nlm.nih.gov/pubmed/20713880